These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31278167)

  • 21. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure.
    Colby JM
    Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of drug use in pregnant West Virginia patients.
    Stitely ML; Calhoun B; Maxwell S; Nerhood R; Chaffin D
    W V Med J; 2010; 106(4 Spec No):48-52. PubMed ID: 21932753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method.
    Wu F; Jensen TL; McMillin GA
    Methods Mol Biol; 2019; 1872():211-222. PubMed ID: 30350293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological Testing and Interpretation of Laboratory Results Associated with Detecting Newborns with Substance Exposure.
    McMillin GA; Morad AW; Boyd JM; Johnson-Davis KL; Metz TD; Smid MC; Krasowski MD
    Clin Chem; 2024 Jul; 70(7):934-947. PubMed ID: 38549034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D metabolite concentrations in umbilical cord blood serum and associations with clinical characteristics in a large prospective mother-infant cohort in Ireland.
    Kiely M; O'Donovan SM; Kenny LC; Hourihane JO; Irvine AD; Murray DM
    J Steroid Biochem Mol Biol; 2017 Mar; 167():162-168. PubMed ID: 28007533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underestimation of substance abuse in psychiatric patients by conventional hospital screening.
    Reidy LJ; Junquera P; Van Dijck K; Steele BW; Nemeroff CB
    J Psychiatr Res; 2014 Dec; 59():206-12. PubMed ID: 25262418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry.
    Ristimaa J; Gergov M; Pelander A; Halmesmäki E; Ojanperä I
    Anal Bioanal Chem; 2010 Sep; 398(2):925-35. PubMed ID: 20617307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meconium testing for cocaine metabolite: prevalence, perceptions, and pitfalls.
    Rosengren SS; Longobucco DB; Bernstein BA; Fishman S; Cooke E; Boctor F; Lewis SC
    Am J Obstet Gynecol; 1993 May; 168(5):1449-56. PubMed ID: 8498426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal screening for drugs of abuse: reassessment of current practice in a high-risk area.
    Schulman M; Morel M; Karmen A; Chazotte C
    Am J Perinatol; 1993 Sep; 10(5):374-7. PubMed ID: 8240597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
    Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
    Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discordant Umbilical Cord Drug Testing Results in Monozygotic Twins.
    Alexander A; Abbas L; Jones M; Jones J; Lewis D; Negrusz A
    J Anal Toxicol; 2018 Jun; 42(5):e47-e49. PubMed ID: 29462321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of emerging drugs of abuse in Hong Kong: validation of an analytical tool.
    Tang M; Ching CK; Tse ML; Ng C; Lee C; Chong YK; Wong W; Mak TW;
    Hong Kong Med J; 2015 Apr; 21(2):114-23. PubMed ID: 25756277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A descriptive regional study of drug and alcohol use in pregnant women using results from urine drug testing by liquid chromatography-tandem mass spectrometry.
    Kreshak A; Villano J; Clark A; Deak P; Clark R; Miller C
    Am J Drug Alcohol Abuse; 2016 Mar; 42(2):178-86. PubMed ID: 26811262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of opioids in umbilical cord lysates: an antibody-based rapid screening approach.
    Knight SJ; Smith AD; Wright TE; Collier AC
    Toxicol Mech Methods; 2019 Jan; 29(1):35-42. PubMed ID: 30064290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of in utero marijuana exposure by GC-MS, ultra-sensitive ELISA and LC-TOF-MS using umbilical cord tissue.
    Chittamma A; Marin SJ; Williams JA; Clark C; McMillin GA
    J Anal Toxicol; 2013 Sep; 37(7):391-4. PubMed ID: 23843423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in drug use from urine drug testing of addiction treatment clients.
    Kirsh KL; Heit HA; Huskey A; Strickland J; Egan K; Passik SD
    J Opioid Manag; 2015; 11(1):61-8. PubMed ID: 25750166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meconium drug testing in multiple births in the USA.
    Wood KE; Krasowski MD; Strathmann FG; McMillin GA
    J Anal Toxicol; 2014 Sep; 38(7):397-403. PubMed ID: 24927721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing a perinatal substance abuse screening tool.
    Wallman CM; Smith PB; Moore K
    Adv Neonatal Care; 2011 Aug; 11(4):255-67. PubMed ID: 22123347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.